Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

OBJECTIVE: Gabapentin and its prodrug are candidate therapeutic agents for akathisia. An open-label pilot study was conducted to investigate the therapeutic potential of gabapentin enacarbil (GE) for akathisia. METHODS: In an open-labeled investigator-initiated clinical trial, nine outpatients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshima, Masahiro, Ishikawa, Hiroyasu, Kanbayashi, Takashi, Shimizu, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257366/
https://www.ncbi.nlm.nih.gov/pubmed/30538475
http://dx.doi.org/10.2147/NDT.S184081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257366/
https://www.ncbi.nlm.nih.gov/pubmed/30538475
http://dx.doi.org/10.2147/NDT.S184081

Ejemplares similares